In this study, the prevalence rate of nasal carriage of
S. aureus was similar to the nasal carriage rate in Italy (39.2%) (
16). This rate was lower than what was found in previous studies in Syria (48%) (
12) and Ethiopia (47.74%) (
17). However, our results were higher than what was found in Iraq (17.5% - 30%) (
6,
18-
20), Iran (28%) (
21), India (25%) (
22), Thailand (29.7%) (
23), and Malaysia (31%) (
24). This variation in rates among different populations might be due to the differences in standards used in performing the lab work and sample size.
We found that the highest rate of antibiotics resistance was against oxacillin (35%), and this was higher than what was found in previous studies conducted in Syria (9.4%) (
12) and Iraq (2.04% - 21.95%) (
6,
19,
20), and no oxacillin resistant isolates were found in Malaysia (
24). The rate was lower than that in Nigeria (47.15%) (
25), which might be due to the misuse of antibiotics especially in developing countries where individuals can obtain antibiotics easily and without prescription.
Vancomycin serves as an alternative drug of choice for treating MRSA infections. The resistance rate of
S. aureus against vancomycin in the present study was 11.4%. This rate was higher than what was found in Syria (1.9%) (
12) and China (4.4%) (
26). Besides, it was also observed that no resistance was found against vancomycin in different studies in Iraq (
5,
20,
27), Ethiopia (
17), and the United States of America (USA) (
28). With the high rate of resistance to vancomycin, it increases the challenge of treating infections caused by multi-drug resistant
S. aureus.
On the other hand, we found a lower resistance rate to tetracycline than what was found in Iraq (25%) (
27) and Thailand (34.2%) (
23), while it was higher than the reports from Nepal (20%) (
5), Malaysia (17.3%) (
24), and Ethiopia (16.9%) (
17).
Furthermore, we found that the resistance rate to gentamicin was 17.86%, which is higher than those rates reported in Iraq (3.22%) (
27) and Ethiopia (1.5 %) (
17) and lower than the reports from Nepal (33.3%) (
5) and USA (30%) (
28). Furthermore, about 8.57% of
S. aureus isolates showed resistance to ciprofloxacin. This rate was lower than what was found in Nepal (36.7%) (
5), Iraq (19%) (
27), and the USA (65%) (
28). However, another study conducted in Iraq showed that all isolates were sensitive to ciprofloxacin (
20).
The resistance rates of
S. aureus to rifampicin and clindamycin were 2.86% and 2.14%, respectively. The rifampicin resistance rate in the present study was higher than what was found in the USA (0%) (
28). However, the clindamycin resistance rate (2.14%) was lower than the results of a study conducted in Syria (21.64%) (
12), Nepal (13.3%) (
5), Thailand (63.2%) (
23) and USA (57%), while the resistance rate was similar to the rate reported in Malaysia (2.2%) (
24). In addition, we found that all
S. aureus isolates were sensitive to teicoplanin. Our finding was similar to what was found in Nepal (
5). This similarity is difficult to explain, and further research is needed to explore this. The variation in resistance rates to different types of antibiotics included in the study could be due to the variation in different factors such as the age group of participants, gender, and laboratory standards. Besides, the misuse of antibiotics plays an important role in spreading the resistance genes among the population.
However, our study recruited a limited number of refugees on the point of arrival in Iraq. This was due to the difficulty in accessing Iraqi-Syrian borders due to regional insecurity. Thus, further studies recruiting larger sample sizes are recommended to determine the concise status of the prevalence rate of microorganisms in the Syrian community.
5.1. Conclusions
This study focused on finding the nasal carriage rate and determining the antibiotics susceptibility profile of S. aureus isolates among Syrian refugees in Iraq. The highest rate was against oxacillin, and all isolates were sensitive to teicoplanin. Vancomycin susceptibility testing showed a significant rate of resistance, and this increased the challenge of treating infections caused by multi-drug resistant S. aureus. Further studies are needed to investigate the molecular base of antibiotics resistance in this microorganism.